UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-A/A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PUSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
A2017BVXLOGOA04.JPG
BOVIE MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
11-2644611
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
5115 Ulmerton Road, Clearwater, FL 33760
(Address of principal executive offices, zip code)

Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be registered
 
Name of exchange on which each class is to be registered
 
 
 
Common Stock, $0.001 par value
 
The NASDAQ Stock Market LLC
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ý

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. o

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. o

Securities Act registration statement file number to which this form relates: N/A

Securities to be registered pursuant to Section 12(g) of the Act:

Not applicable
(Title of class)






Item 1. Description of Registrant’s Securities to be Registered.

A description of the common stock, $.001 par value per share, of Bovie Medical Corporation (the “Company”) set forth in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13, 2018 is hereby incorporated by reference into this Item 1.

Item 2. Exhibits.

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed hereunder because no other securities of the Company are listed by The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.






SIGNATURES

Pursuant to the requirements of Section l2 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

Date: December 31, 2018
BOVIE MEDICAL CORPORATION
 
 
 
 
 
By:
/s/ Charles D. Goodwin II
 
 
 
Charles D. Goodwin II
 
 
 
Chief Executive Officer
 



Bovie (AMEX:BVX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bovie Charts.
Bovie (AMEX:BVX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bovie Charts.